Navigation Links
STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter
Date:11/2/2009

MONROVIA, Calif., Nov. 2 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported that it generated $464,000 in cash from operating activities during the third quarter. The cash generated was the largest amount from operating activities for any quarterly period in the past six years. This achievement was made possible due to continued significant progress in the management of domestic operating expense despite recording over $400,000 in legal expenses during the quarter related to former sales representative litigation, net of approximately $300,000 in estimated insurance recoveries.

Third Quarter Financial Highlights

  • Cash provided by operating activities was $464,000, compared to cash used in operating activities of $1.1 million during the third quarter of 2008. This reflects continuous improvement for the past seven quarters as shown below:
              CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES (000'S)

    Q1 2008   Q2 2008  Q3 2008  Q4 2008  Q1 2009  Q2 2009  Q3 2009
    --------  -------  -------  -------  -------  -------  -------
    ($3,370)  ($2,760) (1,107)   ($991)   ($448)    $286     $464
    -------   -------  ------    -----    -----     ----     ----



  • Global sales for the third quarter were $18.1 million, unchanged on a constant currency basis, as compared to $18.1 million during the third quarter of 2008. Global sales for the third quarter of 2009 were impacted by the Company's decision in late 2008 to de-emphasize sales of low margin products. Sales of these lower margin products declined by 15% or $821,000 during the third quarter and represented 26% of total sales versus 30% in the third quarter of 2008. For the nine mo
    '/>"/>

SOURCE STAAR Surgical Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related medicine technology :

1. STAAR Surgical to Present at the 20th Annual Oppenheimer Healthcare Conference in New York
2. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
3. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
4. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
5. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
6. New Non-Surgical Stem-Cell Procedure to Relieve Chronic Tendon Problems
7. Ceremeds OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
8. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
9. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
10. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
11. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... , October 22, 2014 ... ), a clinical-stage pharmaceutical company focused on the ... positive top-line clinical results from its Phase IIa ... insulin capsules, to treat type 1 diabetes. The trial ... under a U.S. Food and Drug ...
(Date:10/22/2014)... 2014 Abaxis, Inc. (NasdaqGS: ABAX ... systems, today reported financial results for the second fiscal ... overview: , Revenues of $53.9 million, up 18% ... of $0.24, up 33% over last year,s comparable quarter. ... Abaxis Veterinary Reference Laboratories (AVRL) of $3.5 million, up ...
(Date:10/22/2014)... , Oct. 22, 2014 InVivo Therapeutics Holdings ... is revolutionizing spinal cord injury (SCI) treatment ... shown to outperform in tissue regrowth in the spinal ... Made from an FDA approved polymer, the scaffold ultimately ... harmless to the human body. NVIV has recently attracted ...
Breaking Medicine Technology:Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 2Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 3Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 4Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 5Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 6Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 7Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 8Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 9Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 10Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 11Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 12Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 13Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 14InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3
... GT Life Sciences, Inc., (GT) a privately held ... 7,856,317 for "SYSTEMS AND METHODS FOR CONSTRUCTING GENOMIC-BASED PHENOTYPIC ...  The ,317 patent has a priority date of June ... systems and complex modeling processes by which scientists may ...
... NEW YORK, May 12, 2011 Reportlinker.com ... is available in its catalogue: ... to 2017 http://www.reportlinker.com/p0493115/Asia-Pacific-Hospital-Supplies-Market-Outlook-to-2017.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic ... Market Outlook to 2017 ...
Cached Medicine Technology:GT Life Sciences Broadens Intellectual Property Portfolio with Issuance of U.S. Patent on Core Computational Systems and Methods for Genomic-based Metabolic Modeling 2GT Life Sciences Broadens Intellectual Property Portfolio with Issuance of U.S. Patent on Core Computational Systems and Methods for Genomic-based Metabolic Modeling 3Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 2Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 3Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 4Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 5Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 6Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 7Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 8Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 9Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 10Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 11Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 12Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 13Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 14Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 15
(Date:10/22/2014)... October 22, 2014 On October 22, ... featuring skin diseases both fictional and real. The ... a nonprofit organization committed to advocacy and philanthropy in ... will take the opportunity to impart truth and clarity ... , There are many misconceptions about Morgellons Disease ...
(Date:10/22/2014)... TUESDAY, Oct. 21, 2014 (HealthDay News) -- The ... passengers arriving from Ebola-affected nations of West Africa ... screen them for infection with the virus. ... Jeh Johnson noted that 94 percent of air ... land at one of these five airports -- ...
(Date:10/22/2014)... 2014 During the Western United States’ ... runs dangerously low, Southern Oregon’s water is proving resistant ... the lowest mountain snow pack on record in 2014, ... early autumn.* That was the observation of journalist-hikers Art ... “Hiking Southern Oregon,” during an interview with water advocate ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Lintelus, Inc., ... Sr. Vice President of Sales, will be speaking on ... Meetings Technology Expo on October 28, at the Holiday ... hosting a booth as well as a Tech Demo ... Meeting can create a more engaging event experience. , ...
(Date:10/22/2014)... sisters in high school have developed ways to measure ... use electronic stethoscopes, which electronically amplify body sounds, to ... heartbeats. Ilina, a senior at Port Huron Northern ... to detect early lung damage in people exposed to ... one breath cycle each from 16 smokers, 25 nonsmokers ...
Breaking Medicine News(10 mins):Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 2Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 4Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2
... than three million babies worldwide are conceived through Assisted ... intra-uterine induction. ,In Britain, ART accounts for ... 10,242 in 2004 while many more women undergo ... is 28.2 per cent, falling to 10.6 per cent ...
... genes that are associated with resistance to chemotherapeutic drugs ... significantly enhance the ability to predict whether or ... functional genomic screen. ,Resistance to chemotherapeutic drugs ... with metastatic cancer. Dr. Julian Downward from the Cancer ...
... water or coke when thirsty; instead get a can of Tea Cola, ... still in the mood for a cup of tea , just pop ... developed the exotic health drink and the pill from tea extracts are ... granted provisional patent rights. ,"It would be a milestone in ...
... legend Sir Elton John performed a free gig in ... place in the country's capital Kiev, was attended by ... politicians. ,The charity performance of the singer ... received mixed reviews from the people, with some appreciating ...
... out of sponsoring Lindsay Lohan's birthday bash, but now another ... as well as jailed pal Paris Hilton a service ... to go clubbing or partying." ,According to the ... home after a wild night of partying and boozing. Lohan ...
... cheer to the capital with most people indulging in outdoor activities, ... ,As the city received 104.7 mm of rain in ... receives in the month of June, the city faced waterlogging problems. ... family went to India Gate to simply enjoy the weather out ...
Cached Medicine News:Health News:Questions Raised Over Safety of In-vitro Fertilization 2Health News:Questions Raised Over Safety of In-vitro Fertilization 3Health News:Questions Raised Over Safety of In-vitro Fertilization 4Health News:New Genetic Studies Carried Out in Cancer Therapy 2Health News:Tea Pill, Tea Cola Hitting Markets Soon 2
Used for dilation of a tract to the kidney for removal of stones. Supplied sterile in peel-open packages. Intended for one-time use....
... for Urinary Control offers a revolutionary ... the symptoms of overactive bladder, including ... of urgency-frequency alone or in combination ... could not tolerate more conservative treatments. ...
... ELPHA 4 Conti is a battery operated dual-channel ... of conditions described below. ELPHA 4 Conti also ... STRESS- and faecal incontinence ELPHA 4 Conti provokes ... the user can feel which muscles need exercising. ...
... Set is the HDR solution which duplicates ... The template set consists of a small ... to the patient and is placed in ... Face Plates. The Stepper Holder is available ...
Medicine Products: